GB0128376D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0128376D0
GB0128376D0 GBGB0128376.1A GB0128376A GB0128376D0 GB 0128376 D0 GB0128376 D0 GB 0128376D0 GB 0128376 A GB0128376 A GB 0128376A GB 0128376 D0 GB0128376 D0 GB 0128376D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0128376.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB0128376.1A priority Critical patent/GB0128376D0/en
Publication of GB0128376D0 publication Critical patent/GB0128376D0/en
Priority to AU2002365510A priority patent/AU2002365510A1/en
Priority to ARP020104525A priority patent/AR037426A1/es
Priority to US10/496,159 priority patent/US7038055B2/en
Priority to AT02790435T priority patent/ATE299497T1/de
Priority to ES02790435T priority patent/ES2243783T3/es
Priority to DE60205035T priority patent/DE60205035T2/de
Priority to EP02790435A priority patent/EP1448529B1/en
Priority to PCT/EP2002/013263 priority patent/WO2003045922A1/en
Priority to JP2003547374A priority patent/JP2005513034A/ja
Priority to TW091134148A priority patent/TW200303746A/zh
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
GBGB0128376.1A 2001-11-27 2001-11-27 Novel compounds Ceased GB0128376D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0128376.1A GB0128376D0 (en) 2001-11-27 2001-11-27 Novel compounds
TW091134148A TW200303746A (en) 2001-11-27 2002-11-25 Novel compounds
AT02790435T ATE299497T1 (de) 2001-11-27 2002-11-25 Zur behandlung von autoimmunerkrankungen und allergien geeignete sulfonderivate
ARP020104525A AR037426A1 (es) 2001-11-27 2002-11-25 Compuesto de quinolina, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento para prepararlo y compuestos de quinolina de utilidad como intermediarios en dicho procedimiento
US10/496,159 US7038055B2 (en) 2001-11-27 2002-11-25 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies
AU2002365510A AU2002365510A1 (en) 2001-11-27 2002-11-25 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies
ES02790435T ES2243783T3 (es) 2001-11-27 2002-11-25 Derivados de sulfona apropiadas para el tratamiento de enfermedades autoinmunes y alergias.
DE60205035T DE60205035T2 (de) 2001-11-27 2002-11-25 Zur behandlung von autoimmunerkrankungen und allergien geeignete sulfonderivate
EP02790435A EP1448529B1 (en) 2001-11-27 2002-11-25 Sulfone derivatives suitable for the treatment of autoimmune diseases and allergies
PCT/EP2002/013263 WO2003045922A1 (en) 2001-11-27 2002-11-25 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies
JP2003547374A JP2005513034A (ja) 2001-11-27 2002-11-25 スルホン誘導体ならびに自己免疫疾患およびアレルギーの治療におけるその使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0128376.1A GB0128376D0 (en) 2001-11-27 2001-11-27 Novel compounds

Publications (1)

Publication Number Publication Date
GB0128376D0 true GB0128376D0 (en) 2002-01-16

Family

ID=9926523

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0128376.1A Ceased GB0128376D0 (en) 2001-11-27 2001-11-27 Novel compounds

Country Status (11)

Country Link
US (1) US7038055B2 (enExample)
EP (1) EP1448529B1 (enExample)
JP (1) JP2005513034A (enExample)
AR (1) AR037426A1 (enExample)
AT (1) ATE299497T1 (enExample)
AU (1) AU2002365510A1 (enExample)
DE (1) DE60205035T2 (enExample)
ES (1) ES2243783T3 (enExample)
GB (1) GB0128376D0 (enExample)
TW (1) TW200303746A (enExample)
WO (1) WO2003045922A1 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706255D0 (en) * 1997-03-26 1997-05-14 Smithkline Beecham Plc Novel compounds
EP1001930B1 (en) 1997-07-31 2002-12-04 Abbott Laboratories N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
US6100266A (en) 1998-01-30 2000-08-08 Darwin Discovery Limited Hydroxamic and carboxylic acid derivatives
NZ522594A (en) * 2000-05-25 2004-05-28 Smithkline Beecham P Bicyclyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides

Also Published As

Publication number Publication date
ES2243783T3 (es) 2005-12-01
AR037426A1 (es) 2004-11-10
US7038055B2 (en) 2006-05-02
EP1448529A1 (en) 2004-08-25
EP1448529B1 (en) 2005-07-13
TW200303746A (en) 2003-09-16
JP2005513034A (ja) 2005-05-12
AU2002365510A1 (en) 2003-06-10
DE60205035T2 (de) 2005-12-29
ATE299497T1 (de) 2005-07-15
DE60205035D1 (de) 2005-08-18
US20050070572A1 (en) 2005-03-31
WO2003045922A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
GB0105895D0 (en) Novel compounds
AU2002359165A8 (en) Novel compounds
GB0106586D0 (en) Novel compounds
GB0104259D0 (en) Novel compounds
GB0102713D0 (en) Novel compounds
GB0103866D0 (en) Novel compounds
GB0102470D0 (en) Novel compounds
GB0100186D0 (en) Novel compounds
GB0100182D0 (en) Novel compounds
GB0103175D0 (en) Novel compounds
GB0102714D0 (en) Novel compounds
GB0104970D0 (en) Novel compounds
GB0102711D0 (en) Novel compounds
GB0102578D0 (en) Novel Compounds
GB0102577D0 (en) Novel Compounds
GB0102576D0 (en) Novel compounds
GB0102575D0 (en) Novel Compounds
GB0102571D0 (en) Novel Compounds
GB0102570D0 (en) Novel Compounds
GB0105095D0 (en) Novel compounds
GB0102469D0 (en) Novel compounds
GB0101437D0 (en) Novel Compounds
GB0101334D0 (en) Novel compounds
GB0100187D0 (en) Novel compounds
GB0107389D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)